Levofloxacin and indolicidin for combination antimicrobial therapy

Current Drug Delivery

Volumn 12, Issue 1, 2015, Pages 108-114

  Ghaffar, Khairunnisa Abdul ^a   Hussein, Waleed M ^a   Khalil, Zeinab G ^a   Capon, Robert J ^a   Skwarczynski, Mariusz ^a   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antibiotic; Conjugation; Indolicidin; Levofloxacin; TAT peptide

Indexed keywords

CELL PENETRATING PEPTIDE; GLYCINE; GLYCOLIC ACID; INDOLICIDIN; LEVOFLOXACIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; DRUG CARRIER; DRUG COMBINATION; PEPTIDE FRAGMENT; TRANSACTIVATOR PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HEMOLYSIS; MEDICINAL CHEMISTRY; METABOLISM; MICROBIAL SENSITIVITY TEST; PHARMACEUTICS; PROCEDURES;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL-PENETRATING PEPTIDES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMBINATIONS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; LEVOFLOXACIN; MICROBIAL SENSITIVITY TESTS; PEPTIDE FRAGMENTS; SOLID-PHASE SYNTHESIS TECHNIQUES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84930908903     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666140910094050     Document Type: Article

References (36)

1. Cooper, M. A.; Shlaes, D. Fix the antibiotics pipeline. Nature (London, U. K.), 2011, 472, 32.
2. Choi, H.; Lee, D. G. Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria. Res., Microbiol., 2012, 163, 479-486.
3. Zhang, Y.; Liu, Y.; Sun, Y.; Liu, Q.; Wang, X.; Li, Z.; Hao, J. In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates. Curr. Microbiol., 2014, 68, 685-692.
4. Anderson, V. R.; Perry, C. M. Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infection. Drugs, 2008, 68, 535-565.
5. Bauernfeind, A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J. Antimicrob. Chemother., 1997, 40, 639-651.
6. Hurst, M.; Lamb, H. M.; Scott, L. J.; Figgitt, D. P. Levofloxacin: An updated review of its use in the treatment of bacterial infections. Drugs, 2002, 62, 2127-2167.
7. Fukuda, H.; Hiramatsu, K. Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 1999, 43, 410-412.
8. Hooper, D. C. Mode of action of fluoroquinolones. Drugs, 1999, 58, 6-10.
9. Langtry, H. D.; Lamb, H. M. Levofloxacin Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 1998, 56, 487-515.
10. Morrissey, I.; George, J. T. Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones. J. Antimicrob. Chemother., 2000, 45, 101-106.
11. Hurst, M.; Lamb, H. M.; Scott, L. J.; Figgitt, D. P. Levofloxacin; An Updated Review of Its Use in the Treatment of Bacterial Infections. Drugs, 2002, 62, 2127-2167.
12. Jang, W. H.; Yoo, D. H.; Park, S. W. Prevalence of and risk factors for levofloxacin-resistant E. coli Isolated from outpatients with urinary tract infection. Korean J. Urol., 2011, 52, 554-559.
13. Ibrahim, M. A.; Panda, S. S.; Birs, A. S.; Serrano, J. C.; Gonzalez, C. F.; Alamry, K. A.; Katritzky, A. R. Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates. Bioorg. Med. Chem. Lett., 2014, 24, 1856-1861.
14. Wang, X. D.; Wei, W.; Wang, P. F.; Tang, Y. T.; Deng, R. C.; Li, B.; Zhou, S. S.; Zhang, J. W.; Zhang, L.; Xiao, Z. P.; Ouyang, H.; Zhu, H. L. Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. Bioorg. Med. Chem., 2014, 22, 3620-3628.
15. Pokrovskaya, V.; Belakhov, V.; Hainrichson, M.; Yaron, S.; Baasov, T. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics. J. Med. Chem., 2009, 52, 2243-2254.
16. Butler, M. M.; Lamarr, W. A.; Foster, K. A.; Barnes, M. H.; Skow, D. J.; Lyden, P. T.; Kustigian, L. M.; Zhi, C.; Brown, N. C.; Wright, G. E.; Bowlin, T. L. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound. Antimicrobial Agents Chemother., 2007, 51, 119-127.
17. Subbalakshmi, C.; Sitaram, N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett., 1998, 160, 91-96.
18. Selsted, M. E.; Novotny, M. J.; Morris, W. L.; Tang, Y. Q.; Smith, W.; Cullor, J. S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem., 1992, 267, 4292-4295.
19. Selsted, M. E.; Novotny, M. J.; Morris, W. L.; Tang, Y. Q.; Smith, W.; Cullor, J. S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem., 1992, 267, 4292-4295.
20. Ahmad, I.; Perkins, W. R.; Lupan, D. M.; Selsted, M. E.; Janoff, A. S. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim. Biophys. Acta, Biomembr., 1995, 1237, 109-114.
21. Aley, S. B.; Zimmerman, M.; Hetsko, M.; Selsted, M. E.; Gillin, F. D. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect. Immun., 1994, 62, 5397-5403.
22. Schluesener, H. J.; Radermacher, S.; Melms, A.; Jung, S. Leukocytic antimicrobial peptides kill autoimmune T cells. J. Neuroimmunol., 1993, 47, 199-202.
23. Kerkis, A.; Hayashi, M.; Yamane, T.; Kerkis, I. Properties of cell penetrating peptides (CPPs). IUBMB Life, 2006, 58, 7-13.
24. Sebbage, V. Cell-penetrating peptides and their therapeutic applications. Biosci. Horiz., 2009, 2, 64-72.
25. Al-Taei, S.; Penning, N. A.; Simpson, J. C.; Futaki, S.; Takeuchi, T.; Nakase, I.; Jones, A. T. Intracellular Traffic and Fate of Protein Transduction Domains HIV-1 TAT Peptide and Octaarginine. Implications for Their Utilization as Drug Delivery Vectors. Bioconjug. Chem., 2006, 17, 90-100.
26. Chauhan, A.; Tikoo, A.; Kapur, A. K.; Singh, M. The taming of the cell penetrating domain of the HIV TAT: Myths and realities. J. Control. Release, 2007, 117, 148-162.
27. Torchilin, V. P.; Levchenko, T. S. TAT-liposomes: A novel intracellular drug carrier. Curr. Protein Pept. Sci., 2003, 4, 133-140.
28. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 13003-13008.
29. Drlica, K.; Zhao, X. L. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev., 1997, 61, 377-392.
30. Shaw, J. E.; Epand, R. F.; Hsu, J. C. Y.; Mo, G. C. H.; Epand, R. M.; Yip, C. M. Cationic peptide-induced remodelling of model membranes: Direct visualization by in situ atomic force microscopy. J. Struct. Biol., 2008, 162, 121-138.
31. Bolla, J.-M.; Alibert-Franco, S.; Handzlik, J.; Chevalier, J.; Mahamoud, A.; Boyer, G.; Kieć-Kononowicz, K.; Pages, J.-M. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria. FEBS Lett., 2011, 585, 1682-1690.
32. Aoki, W.; Ueda, M. Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics. Pharmaceuticals (Basel, Switzerland), 2013, 6, 1055-1081.
33. Liu, T.-Y.; Hussein, W. M.; Jia, Z.; Ziora, Z. M.; McMillan, N. A. J.; Monteiro, M. J.; Toth, I.; Skwarczynski, M. Self-Adjuvanting Polymer-Peptide Conjugates As Therapeutic Vaccine Candidates against Cervical Cancer. Biomacromolecules, 2013, 14, 2798-2806.
34. Apte, S. H.; Groves, P. L.; Skwarczynski, M.; Fujita, Y.; Chang, C.; Toth, I.; Doolan, D. L. Vaccination with Lipid Core Peptides Fails to Induce Epitope-Specific T Cell Responses but Confers Non-Specific Protective Immunity in a Malaria Model. PLoS One, 2012, 7, e40928.
35. Yoshiya, T.; Taniguchi, A.; Sohma, Y.; Fukao, F.; Nakamura, S.; Abe, N.; Ito, N.; Skwarczynski, M.; Kimura, T.; Hayashi, Y.; Kiso, Y. "O-acyl isopeptide method" for peptide synthesis: synthesis of forty kinds of "O-acyl isodipeptide unit" Boc-Ser/Thr(Fmoc-Xaa)-OH. Org. Biomol. Chem., 2007, 5, 1720-1730.
36. Krchnak, V.; Weichsel, A. S.; Cabel, D.; Flegelova, Z.; Lebl, M. Structurally homogeneous and heterogeneous synthetic combinatorial libraries. Mol. Divers., 1996, 1, 149-164.